• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伤寒沙门氏菌的宿主限制、发病机制和慢性携带。

Host restriction, pathogenesis and chronic carriage of typhoidal Salmonella.

机构信息

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LE, UK.

National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford OX4 2PG, UK.

出版信息

FEMS Microbiol Rev. 2021 Sep 8;45(5). doi: 10.1093/femsre/fuab014.

DOI:10.1093/femsre/fuab014
PMID:33733659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8498562/
Abstract

While conjugate vaccines against typhoid fever have recently been recommended by the World Health Organization for deployment, the lack of a vaccine against paratyphoid, multidrug resistance and chronic carriage all present challenges for the elimination of enteric fever. In the past decade, the development of in vitro and human challenge models has resulted in major advances in our understanding of enteric fever pathogenesis. In this review, we summarise these advances, outlining mechanisms of host restriction, intestinal invasion, interactions with innate immunity and chronic carriage, and discuss how this knowledge may progress future vaccines and antimicrobials.

摘要

虽然伤寒的结合疫苗最近已被世界卫生组织推荐使用,但副伤寒、多药耐药和慢性带菌的疫苗仍缺乏,这对肠道热病的消除带来了挑战。在过去的十年中,体外和人体挑战模型的发展使我们对肠道热病发病机制的理解取得了重大进展。在这篇综述中,我们总结了这些进展,概述了宿主限制、肠道侵袭、与先天免疫和慢性携带的相互作用的机制,并讨论了这些知识如何推动未来疫苗和抗菌药物的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/435ffe62d840/fuab014fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/f5ed410addd6/fuab014fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/595e610f1dc5/fuab014fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/17f39fbcdf54/fuab014fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/31e4fa5de4e0/fuab014fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/435ffe62d840/fuab014fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/f5ed410addd6/fuab014fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/595e610f1dc5/fuab014fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/17f39fbcdf54/fuab014fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/31e4fa5de4e0/fuab014fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d220/8498562/435ffe62d840/fuab014fig5.jpg

相似文献

1
Host restriction, pathogenesis and chronic carriage of typhoidal Salmonella.伤寒沙门氏菌的宿主限制、发病机制和慢性携带。
FEMS Microbiol Rev. 2021 Sep 8;45(5). doi: 10.1093/femsre/fuab014.
2
Vi Capsular Polysaccharide Produced by Recombinant Serovar Paratyphi A Confers Immunoprotection against Infection by Serovar Typhi.重组甲型副伤寒 Vi 荚膜多糖对伤寒血清型感染具有免疫保护作用。
Front Cell Infect Microbiol. 2017 Apr 24;7:135. doi: 10.3389/fcimb.2017.00135. eCollection 2017.
3
A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever.肠热病疫苗的免疫概况及近期发展状况简述。
Vaccine. 2017 Nov 7;35(47):6359-6366. doi: 10.1016/j.vaccine.2017.09.066. Epub 2017 Oct 12.
4
Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: A prophylactic study in BALB/c mice.基于细菌空壳细胞的伤寒沙门氏菌和甲型副伤寒沙门氏菌二价候选疫苗:BALB/c 小鼠的预防性研究。
Vaccine. 2023 Sep 22;41(41):5994-6007. doi: 10.1016/j.vaccine.2023.08.049. Epub 2023 Aug 23.
5
Vaccine value profile for Salmonella enterica serovar Paratyphi A.伤寒 A 血清型沙门氏菌疫苗价值概况。
Vaccine. 2023 Nov 3;41 Suppl 2:S114-S133. doi: 10.1016/j.vaccine.2023.01.054. Epub 2023 Oct 6.
6
Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.肠靶向交叉免疫反应对伤寒和口服 Ty21a 伤寒疫苗接种后血清型 A 和 B 沙门氏菌的影响。
Vaccine. 2012 Sep 14;30(42):6047-53. doi: 10.1016/j.vaccine.2012.07.051. Epub 2012 Aug 2.
7
Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.对口服伤寒沙门氏菌Ty21a疫苗和肠外Vi荚膜多糖伤寒疫苗同时接种的特异性和交叉反应性免疫应答。
Vaccine. 2015 Jan 9;33(3):451-8. doi: 10.1016/j.vaccine.2014.11.030. Epub 2014 Nov 26.
8
Environmental Surveillance as a Tool for Identifying High-risk Settings for Typhoid Transmission.环境监测作为识别伤寒传播高危环境的工具。
Clin Infect Dis. 2020 Jul 29;71(Suppl 2):S71-S78. doi: 10.1093/cid/ciaa513.
9
Status of paratyphoid fever vaccine research and development.副伤寒疫苗研发现状。
Vaccine. 2016 Jun 3;34(26):2900-2902. doi: 10.1016/j.vaccine.2016.03.106. Epub 2016 Apr 12.
10
Typhoid and paratyphoid fever: a clinical seminar.伤寒与副伤寒:临床研讨会。
J Travel Med. 2021 Apr 14;28(3). doi: 10.1093/jtm/taab012.

引用本文的文献

1
Molecular Mechanisms of Intestinal Protection by 23017 against C7731-Induced Damage: Role of Nrf2.23017对C7731诱导损伤的肠道保护分子机制:Nrf2的作用
Microorganisms. 2024 Jun 1;12(6):1135. doi: 10.3390/microorganisms12061135.
2
Transcriptional profiling links unique human macrophage phenotypes to the growth of intracellular Salmonella enterica serovar Typhi.转录谱分析将独特的人类巨噬细胞表型与细胞内伤寒沙门氏菌 Typhi 的生长联系起来。
Sci Rep. 2024 Jun 4;14(1):12811. doi: 10.1038/s41598-024-63588-6.
3
Persistent Salmonella infections in humans are associated with mutations in the BarA/SirA regulatory pathway.

本文引用的文献

1
The Rab32/BLOC-3-dependent pathway mediates host defense against different pathogens in human macrophages.Rab32/ BLOC-3依赖性途径介导人类巨噬细胞对不同病原体的宿主防御。
Sci Adv. 2021 Jan 15;7(3). doi: 10.1126/sciadv.abb1795. Print 2021 Jan.
2
Vi-specific serological correlates of protection for typhoid fever.伤寒血清学保护的 Vi 特异性相关因素。
J Exp Med. 2021 Feb 1;218(2). doi: 10.1084/jem.20201116.
3
Genetic Markers in Paratyphi C Reveal Primary Adaptation to Pigs.丙型副伤寒杆菌中的遗传标记揭示了其对猪的初步适应性。
人类持续性沙门氏菌感染与 BarA/SirA 调节途径中的突变有关。
Cell Host Microbe. 2024 Jan 10;32(1):79-92.e7. doi: 10.1016/j.chom.2023.12.001.
4
Immune evasion and persistence in enteric bacterial pathogens.肠道细菌病原体的免疫逃逸与持续存在。
Gut Microbes. 2023 Jan-Dec;15(1):2163839. doi: 10.1080/19490976.2022.2163839.
5
Through the Looking Glass: Genome, Phenome, and Interactome of .透过镜子:……的基因组、表型组和相互作用组
Pathogens. 2022 May 14;11(5):581. doi: 10.3390/pathogens11050581.
Microorganisms. 2020 Apr 30;8(5):657. doi: 10.3390/microorganisms8050657.
4
IgA and IgG1 Specific to Vi Polysaccharide of Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model.血清型 Vi 多糖的 IgA 和 IgG1 特异性与伤寒感染人体模型中的保护状态相关。
Front Immunol. 2019 Nov 1;10:2582. doi: 10.3389/fimmu.2019.02582. eCollection 2019.
5
Salmonella enterica Requires Lipid Metabolism Genes To Replicate in Proinflammatory Macrophages and Mice.沙门氏菌需要脂质代谢基因在炎症性巨噬细胞和小鼠中复制。
Infect Immun. 2019 Dec 17;88(1). doi: 10.1128/IAI.00776-19.
6
Characterization and protective efficacy of a Salmonella pathogenicity island 2 (SPI2) mutant of Salmonella Paratyphi A.副伤寒 A 沙门氏菌 2 型菌毛岛(SPI2)突变株的特性及其保护效力。
Microb Pathog. 2019 Dec;137:103795. doi: 10.1016/j.micpath.2019.103795. Epub 2019 Oct 11.
7
Current landscape in the discovery of novel antibacterial agents.新型抗菌药物发现的现状。
Clin Microbiol Infect. 2020 May;26(5):596-603. doi: 10.1016/j.cmi.2019.09.015. Epub 2019 Sep 28.
8
Crosstalk between leukocytes triggers differential immune responses against Salmonella enterica serovars Typhi and Paratyphi.白细胞间的串扰引发针对伤寒沙门氏菌血清型 Typhi 和副伤寒沙门氏菌 Paratyphi 的不同免疫应答。
PLoS Negl Trop Dis. 2019 Aug 14;13(8):e0007650. doi: 10.1371/journal.pntd.0007650. eCollection 2019 Aug.
9
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model.在人体挑战模型中研究伤寒毒素在急性伤寒中的作用。
Nat Med. 2019 Jul;25(7):1082-1088. doi: 10.1038/s41591-019-0505-4. Epub 2019 Jul 3.
10
Host inflammasome defense mechanisms and bacterial pathogen evasion strategies.宿主先天免疫防御机制与细菌病原体逃避策略。
Curr Opin Immunol. 2019 Oct;60:63-70. doi: 10.1016/j.coi.2019.05.001. Epub 2019 Jun 4.